Diabetic nephropathy aggravates the progression and prognosis of COVID-19-associated acute limb ischemia

• Main Authors: Decsa M. Hertanto, -, Henry Sutanto, -, Soebagijo Adi Soelistijo, Soebagijo
• Format: Article PeerReviewed
• Language: English; Indonesian; English
• Published: F1000Research Ltd
• Subjects: R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/130893/1/03.%20Artikel.pdf; https://repository.unair.ac.id/130893/2/3%20karil.pdf; https://repository.unair.ac.id/130893/3/03.%20turnitin.pdf; https://repository.unair.ac.id/130893/; https://f1000research.com/articles/10-584; https://doi.org/10.12688/f1000research.54193.2
• Institution: Universitas Airlangga

Abstract Hypercoagulation is a hallmark of both the novel coronavirus disease (COVID-19) and type 2 diabetes mellitus (T2DM). It increases the risk for vascular thrombosis, including peripheral artery diseases. Among others, acute limb ischemia (ALI) is one of most common complications that requires immediate and prompt treatments to reduce morbidity and mortality. However, the complex interplay between COVID-19, T2DM and its complications (e.g., diabetic nephropathy), and ALI creates a great challenge in the management of the disease. Here, we present a case of a 59-year-old diabetic female with progressive pain in her left leg in the last five years, which was significantly intensified following COVID-19 diagnosis. Bluish coloration, numbness and functional impairments were observed during examinations with no palpable pulsation on left posterior tibial and dorsalis pedis arteries. The patient also had diabetic nephropathy (stage III), hypoalbuminemia, anemia and a urinary tract infection that complicated the management of the disease. Due to the excruciating pain and the worsening of the limb conditions, right leg revascularization and left leg amputation were performed at day 14 after admission. Following the surgeries, no more pain was observed and patient was discharged for further follow-up at the outpatient clinic.